Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

Beijing Hotgen Biotech Statistics

Total Valuation

SHA:688068 has a market cap or net worth of CNY 15.09 billion. The enterprise value is 14.04 billion.

Market Cap	15.09B
Enterprise Value	14.04B

Important Dates

The next estimated earnings date is Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	n/a

Share Statistics

SHA:688068 has 88.83 million shares outstanding. The number of shares has increased by 1.50% in one year.

Current Share Class	88.83M
Shares Outstanding	88.83M
Shares Change (YoY)	+1.50%
Shares Change (QoQ)	-4.37%
Owned by Insiders (%)	30.05%
Owned by Institutions (%)	8.71%
Float	59.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	32.39
PB Ratio	5.14
P/TBV Ratio	5.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-60.64
EV / Sales	30.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-359.29

Financial Position

The company has a current ratio of 4.50, with a Debt / Equity ratio of 0.02.

Current Ratio	4.50
Quick Ratio	4.16
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-1.28
Interest Coverage	-217.61

Financial Efficiency

Return on equity (ROE) is -7.66% and return on invested capital (ROIC) is -3.64%.

Return on Equity (ROE)	-7.66%
Return on Assets (ROA)	-3.40%
Return on Invested Capital (ROIC)	-3.64%
Return on Capital Employed (ROCE)	-6.11%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	903
Asset Turnover	0.14
Inventory Turnover	2.24

Taxes

Income Tax	-775,850
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +539.76% in the last 52 weeks. The beta is 1.73, so SHA:688068's price volatility has been higher than the market average.

Beta (5Y)	1.73
52-Week Price Change	+539.76%
50-Day Moving Average	203.51
200-Day Moving Average	128.85
Relative Strength Index (RSI)	38.84
Average Volume (20 Days)	3,134,499

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688068 had revenue of CNY 466.00 million and -231.53 million in losses. Loss per share was -2.54.

Revenue	466.00M
Gross Profit	244.46M
Operating Income	-180.21M
Pretax Income	-236.02M
Net Income	-231.53M
EBITDA	-99.54M
EBIT	-180.21M
Loss Per Share	-2.54

Balance Sheet

The company has 1.10 billion in cash and 50.22 million in debt, giving a net cash position of 1.05 billion or 11.83 per share.

Cash & Cash Equivalents	1.10B
Total Debt	50.22M
Net Cash	1.05B
Net Cash Per Share	11.83
Equity (Book Value)	2.93B
Book Value Per Share	33.07
Working Capital	1.04B

Cash Flow

In the last 12 months, operating cash flow was -15.95 million and capital expenditures -23.13 million, giving a free cash flow of -39.08 million.

Operating Cash Flow	-15.95M
Capital Expenditures	-23.13M
Free Cash Flow	-39.08M
FCF Per Share	-0.44

Margins

Gross margin is 52.46%, with operating and profit margins of -38.67% and -49.69%.

Gross Margin	52.46%
Operating Margin	-38.67%
Pretax Margin	-50.65%
Profit Margin	-49.69%
EBITDA Margin	-21.36%
EBIT Margin	-38.67%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.12%.

Dividend Per Share	0.20
Dividend Yield	0.12%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.50%
Shareholder Yield	-1.38%
Earnings Yield	-1.53%
FCF Yield	-0.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 16, 2022. It was a forward split with a ratio of 1.48.

Last Split Date	Jun 16, 2022
Split Type	Forward
Split Ratio	1.48

Scores

SHA:688068 has an Altman Z-Score of 12.81 and a Piotroski F-Score of 3.

Altman Z-Score	12.81
Piotroski F-Score	3